GGrantIndex
Sort

172,184 grants matching inflammation

Lung Transplant Clinical Trial Network (LT-CTN)

$1,266,035
Scott M Palmer · Duke University · U01 · FY2024 · AI

Center for the Study of Inflammatory Bowel Disease

$1,265,872
Daniel K Podolsky · Massachusetts General Hospital · P30 · FY2007 · DK

Center for the Study of Inflammatory Bowel Disease

$1,265,872
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2009 · DK

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$1,265,745
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Multicenter Uveitis Steroid Treatment (MUST) Trial

$1,265,615
Douglas A Jabs · Icahn School Of Medicine At Mount Sinai · U10 · FY2009 · EY

Pulmonary Valved Graft with Regeneration Potential for Pediatric Patients

$1,265,524
Ajay Houde · Annoviant, Inc · R44 · FY2025 · HL

SCOR IN ACUTE LUNG INJURY

$1,265,449
University Of California San Diego · P50 · FY2003 · HL

Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection

$1,265,431
Robert L Cook · University Of Florida · P01 · FY2025 · AA

Signaling in the retina and retinal pigment epithelium

$1,265,401
Thomas Redmond · National Eye Institute · ZIA · FY2017 · EY

Molecular Regulation of B-Cell Differentiation and Function

$1,265,379
Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Collaborative Integration of HCV Molecular Virology and Mathematical Modeling

$1,265,369
Susan L Uprichard · Loyola University Chicago · R01 · FY2025 · AI

Medical Scientist Research Service Award

$1,265,340
Mark Reid Philips · New York University School Of Medicine · T32 · FY2015 · GM

Development of B-Lock an antibiofilm catheter lock product

$1,264,939
Krzysztof Appelt · Great Lakes Pharmaceuticals, Inc. · R44 · FY2010 · HL

Tissue Injury and Inflammation in Multiple Sclerosis

$1,264,874
Cleveland Clinic Lerner Col/Med-Cwru · P01 · FY2005 · NS

IMProving mobility After revasCularizaTion in Peripheral Artery Disease: the IMPACT PAD Trial

$1,264,646
Mary McGrae McDermott · Northwestern University At Chicago · UG3 · FY2024 · HL

PROMINENT - UCSF

$1,264,382
Allan Balmain · University Of California, San Francisco · OT2 · FY2022 · CA

WU-MDACC Inter-Institutional Molecular Imaging Center

$1,264,315
Samuel Achilefu · Washington University · P50 · FY2014 · CA

Functions and Mechanisms of NF-kB Factors and their Regulators

$1,264,066
Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Integrating Structive Activity, Biokinetics and Response for ENP Risk Assessment

$1,263,983
Joel G Pounds · Battelle Pacific Northwest Laboratories · U19 · FY2010 · ES

NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence

$1,263,938
Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2010 · DA

Basic Research Support for the CCR

$1,263,819
Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA

Physical Resiliencies: Indicators and Mechanisms in the Elderly Collaborative

$1,263,760
Cathleen S Colon-Emeric · Duke University · UH3 · FY2019 · AG

Amazonian Center of Excellence in Malaria Research

$1,263,688
Joseph M. Vinetz · University Of California, San Diego · U19 · FY2017 · AI

Research Center for Pharmacology and Drug Toxicology

$1,263,595
Vanderbilt University · P50 · FY2005 · GM

Role of mouse microbiome in cancer and inflammation

$1,263,350
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA